Navigation Links
Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
Date:11/6/2007

INDIANAPOLIS and DEERFIELD, Ill., Nov. 6 /PRNewswire-FirstCall/ -- In recognition of her research and development of strategies to reduce HIV risk-associated sexual behaviors among African-American, South-African and Latino youth and adults, the Honor Society of Nursing, Sigma Theta Tau International, announced the selection of Loretta Sweet Jemmott, PhD, RN, FAAN, to receive The Baxter International Foundation's 2007 Episteme Award.

Jemmott was presented with the $15,000 award at a special ceremony at the honor society's biennial convention, held November 2-7, 2007, in Baltimore, Md. The Baxter International Foundation sponsors the Episteme Award, presented and selected by the honor society.

Jemott is professor and director of the Center for Health Disparities Research at the University of Pennsylvania School of Nursing. She has built an internationally recognized program of research on HIV prevention interventions for poor and underserved populations.

Jemott developed the "Sister to Sister HIV Risk-Reduction Intervention," an evidenced-based, 20-minute HIV risk-reduction intervention program. The intervention is culturally sensitive, engaging, and gender specific, and can be integrated into primary care clinical practices by nurses and other health care providers. The one-on-one skill-building exercises stress the importance of using condoms to reduce the risk of sexually transmitted infections and HIV.

Jemott's multifaceted research integrates reasoned action, planned behaviors and social cognition with five goals: explain the underlying social psychology factors that create risky sexual behavior; identify theory-based, culturally sensitive and developmentally appropriate strategies to reduce risk; test the effectiveness of interventions using scientifically rigorous methodologies and experimental design; answer practical questions regarding effective implementation; and disseminate evidence-based curricula.

Jemmott has receiv
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
5. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
6. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
7. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...Today at ACG Annual Scientific Meeting -, ORLANDO...Pharmaceuticals, Inc. (formerly Microbia, Inc.) an...nounced the presentation of results from a Phase,2...y in 420 patients with,irritable bowel syndrome wi...cates that once- daily oral dosing of linaclotide,...
(Date:10/7/2008)... 7 /- Aerovance Inc. today reported,p... trial of its Aerovant,inhalation powder that demo...l irritancy following asthma patients, inhalation ...the highest of three doses investigated in,Aerovan...led to begin early,next year. Evidence gathered fr...
(Date:10/7/2008)...andomized Placebo-Controlled Phase II Study Shows ...l Survival., MOUNTAIN VIEW, California, October 7...luated the mature Phase II data from the,therapeut...that had been,obtained as part of the recently ent...e (NCI) in the US., The results from the Phase II...
(Date:10/7/2008)...rt Enrolled in Stage A of Trial Assessing Regimen ...and Paclitaxel -, TUSTIN, Calif., Oct. 7 /PRNewsw...(Nasdaq: PPHM ), a clinical stage biopharmaceutic...e treatment of cancer and,hepatitis C virus (HCV) ...nrollment in the first stage of a Phase II trial o...
Breaking Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report 23877 1Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report 23877 2Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report 23877 3Good Habits for School Success 23874 1Good Habits for School Success 23874 2iCRco Releases Clarity PACS the Clear Solution for Your Digital Radiology Imaging Needs 23869 1iCRco Releases Clarity PACS the Clear Solution for Your Digital Radiology Imaging Needs 23869 2Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments 3F 6517 1Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments 3F 6517 2Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments 3F 6517 3
...he U.S.-based subsidiary of,Pharmexa A/S, presents...today at the Influenza Conference entitled, "Optio...to, Ontario, Canada. The,data show that a "univers...e responses can protect transgenic mice against,le...SOLM, Denmark, June 21, 2007-Pharmexa-Epimmune, th...
... India--(BUSINESS WIRE)--Jun 21, 2007,- The Instit...rmaceutical company, today announced that Phase 3 ...t, Paromomycin IM,Injection (Paromomycin), was pub...rnal of Medicine (NEJM). This clinical trial shows... and well suited,to curing visceral leishmaniasis ...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVi...e management of Trace Life Sciences Inc.,(Trace), ... cyclotron,production facilities in Denton, Texas...., Indium-111, Iodine-123 and Thallium-201 used in,..., NuView Chairman and,CEO, stated that "We are con...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and M...irst-Ever Cancer and Careers Seminar in,Knoxville,...ognition of National,Breast Cancer Awareness Month...e have joined forces with YWCA Knoxville, The Well...vocate Holly Warlick, University of Tennessee,wome...
(Date:10/10/2008)..., The Healthcare Technolo... Care , Exton, PA (PRWEB)... Valley Chapters of the national Healthcare Inform...ined forces to bring regional health information t...ional conference entitled The Healthcare Technolog...
(Date:10/10/2008)..., Boston, MABoston Medical Center (BMC) has recei...tional Institute on Aging (NIA) to fund the Boston...ter. BMC,s Pepper Center is one of only 11 Pepper ...Older Americans Independence Center Program was es....S. senator from Florida. During his five decades ...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2
...the Harvard Medical School, Boston, has confirmed ...k of breast cancer.// A study of more than 100,00... or miscarriage were no more likely to have breast... the study. The findings fit in with a 2003 repor...
...ording to the recent communiqué from US drug revie...promises to contain the HIV virus when used in com...stion named as maraviroc may find a prominent plac...s power to impede the CCR5 co-receptor, the main r...
...l meeting organized to thrash out issues pertainin...opportunity to focus attention on a burning issue ...ies. Amongst the Inuit population of Nunavik, Cana... time high of seven times the national rate- 11.3 ...
...e localized two new genes that are associated with...childhood, according to a study. // “Identifying ...mprove the understanding, treatment and even preve...uthor Rima Nabbout, MD, PhD, of the French Institu...
Other Medicine News:Health News:Abortions Do Not Raise Risk of Breast Cancer 2Health News:Suicide - Aboriginal Communities Take Stock of the Killing Numbers 2
For canalicular laceration or imperforate nasolacrimal duct. Medical grade silicone and Stainless Steel Probe. Box of 3, sterile. Note: Tubing securely swaged into malleable stainless steel probes. S
For reconstruction, trauma and chronic stenosis of canalicular system. Medical grade silicone tubing (tapered at one end). Blue polypropylene suture. Box of 3, sterile.
Disposable Lacrimal Dilators
For proper plug sizing.
Medicine Products: